Price range: $350.00 through $2,500.00
The CJC-1295 + Ipamorelin 10ml vial delivers a sterile, pre-mixed research peptide blend designed for controlled laboratory studies on growth hormone activity and metabolic signaling. Each dose provides 250 mcg of CJC-1295 and 250 mcg of Ipamorelin, which supports consistent experimental modeling.
First, CJC-1295 acts as a growth hormone-releasing hormone (GHRH) analog and extends growth hormone signaling at the pituitary level. In contrast, Ipamorelin functions as a selective growth hormone secretagogue that triggers natural pulsatile release. Together, these mechanisms create a dual-action system that researchers use to observe both sustained and pulse-based hormone responses.
In addition, the 10ml vial format ensures convenient handling in laboratory environments. The sterile solution maintains stability when stored under proper conditions, and it supports repeat dosing for ongoing studies. As a result, researchers can maintain consistency across multiple experimental sessions.
Moreover, this blend supports a wide range of research applications, including endocrine signaling analysis, metabolic pathway studies, protein synthesis research, and recovery-related biological models. Because of its dual mechanism, it offers a flexible tool for studying growth hormone dynamics in a controlled setting.
Finally, this product is intended strictly for research purposes only and is not approved for human consumption, medical use, or therapeutic application.
Ketacyn Pharmaceuticals is a specialized pharmaceutical company dedicated to providing high-quality ketamine-based products for medical use in anesthesia, pain management, and emerging therapeutic applications. Our focus is on ensuring safe, reliable, and compliant delivery of these controlled substances to healthcare professionals and institutions worldwide.
